Medovate brings together the essential finance, technical and management resources required for medical technology development and commercialisation.
In previous roles the Medovate team have successfully managed medtech innovations from concept, through to market launch and onward to successful adoption and global acquisition. The team have key skills developing business cases, protecting intellectual property, prototyping, testing, fundraising and navigating the regulatory pathway to product launch.
Technology Development Pipeline
Medovate’s technology development pipeline is fed through its UK network of NHS researchers and research organisations. As the 5th largest employer in the world, the NHS is a significant innovator of medical technology solutions with the potential to create real value and impact by addressing unmet clinical needs.
Medovate’s network also includes its NHS innovation hub partner, Health Enterprise East, who have a 15 year track record supporting medtech innovation.
Medovate’s current innovation pipeline focus is on anaesthesia, airway, critical care and surgery.
Medovate promotes awareness of essential new technologies created through the development pipeline. This helps healthcare professionals to be able to take advantage of the new technologies available to them to realise improved outcomes for their patients.
Working with relevant networks and organisations, Medovate works to raise the profile amongst medical professionals of revolutionary new medical technologies. For example, Medovate are working with the New York School of Regional Anesthesia (NYSORA) on a programme of activities around the launch of SAFIRA™ in the United States.